Preloaded Monoka (Lacrijet) and congenital nasolacrimal duct obstruction: Initial results

Preloaded Monoka (Lacrijet) and congenital nasolacrimal duct obstruction: Initial results FCI is excited to share the results of a recent study conducted by Bruno Fayet, MD (Paris, France), Jean-Marc Ruban, MD (Lyon, France) and William Katowitz, MD (Philadelphia, USA) on LacriJet®. This article was published last May, in the 'French Journal of Ophthalmology' and highlights the performance of LacriJet® for the management of congenital nasolacrimal duct obstruction (CNLDO).

Download

Download now

Questions about our products?

FCI Ophthalmics
[email protected]

Phone : 800-932-4202
Fax : 781-826-9060